Bayer and Hua Medicine Announce Commercialization Agreement and Strategic Partnership for Investigational First-in-class Novel Diabetes Treatment Dorzagliatin in China
– Investigational first-in-class glucokinase activator, with a novel mode of action, focused on fixing the glucose sensor and restoring glucose
Read More